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Key words: Streptomyces; Bacillus; stringent response; ppGpp; antibiotic production One of the most intriguing challenges in biology is to elucidate the mechanisms by which cells detect and respond to extracellular nutritional conditions. 1) Among the prokaryotes, Bacillus subtilis and Streptomyces spp.
provide tractable experimental systems for studying such mechanisms. These organisms exhibit a wide range of adaptations to extreme nutrient limitation, including the production and secretion of antibiotics and enzymes and the formation of aerial mycelium (Streptomyces spp.) and endospores (Bacillus spp.). Streptomyces coelicolor A3 (2) is the best characterized strain in this genus. It has been used to study mechanisms regulating antibiotic production. [2] [3] [4] This strain produces several chemically diverse antibiotics, including the red-pigmented tripyrrole undecylprodigiosin (Red) and the deep blue-pigmented polyketide actinorhodin (Act). Likewise, B. subtilis has been used as a model organism to study morphological differentiation, i.e., sporulation. 5) Under adverse environmental conditions, such as limited availability of an essential nutrient, bacteria exert stringent control of expression of many genes and enzymes. This ''stringent response'' is one of the most important adaptations by which bacteria survive under harsh conditions (Fig. 1) . Of the various elements of the stringent response, the most prominent is the repression of stable RNA (rRNA and tRNA) synthesis, which has been studied extensively, although almost exclusively in Escherichia coli.
6) The stringent response also includes the direct or indirect activation of the expression of certain genes, including those involved in amino acid biosynthesis. 7) Many studies have shown that the stringent response depends on a transient increase in the levels of a hyperphosphorylated guanosine nucleotide, guanosine tetraphosphate (ppGpp), which is synthesized in response to the binding of uncharged tRNA to the ribosomal A site. Evidence has also suggested that the stringent response plays an intrinsic role in many biological events occurring during the late growth phase.
Based on our findings, we have developed the new concept of ''ribosome engineering'' as a rational approach to elicit cellular function fully. This review summarizes our studies of microbial differentiation and ribosome engineering, on the occasion of an award to me from the Japan Society for Bioscience, Biotechnology, and Agrochemistry.
I. Initiation of Morphological Differentiation
1. Stringent response and differentiation Sporulation of B. subtilis usually starts when the bacilli are placed in a medium containing only slowly metabolizable carbon or nitrogen sources, or no phosphate. In contrast, cells do not sporulate in a medium containing excess glucose, ammonium ions, or phosphate. In B. subtilis [8] [9] [10] [11] and Streptomyces spp., 12, 13) a decrease in the GTP pool size has been found to correlate with the initiation of morphological differentiation. In addition, amino acid auxotrophs that exhibit the stringent response upon amino acid starvation can sporulate when the amino acid supply is reduced but not completely blocked. 14) Amino acid limitation induces the stringent response, as shown by marked reductions in RNA and GTP synthesis and in the rates of many other cellular reactions. This effect is accompanied by increases in intracellular concentrations of ppGpp and pppGpp, compounds responsible for the stringent response. (p)ppGpp is synthesized from GDP or GTP by the relA gene product (RelA/stringent factor/ppGpp synthetase I), which is activated by the binding of uncharged tRNA to the A site via a process that also requires the 50S ribosomal protein L11. Consequently, cells that fail to synthesize (p)ppGpp because they harbor a mutated RelA or L11 protein, and are thus incapable of initiating the stringent response, are termed relaxed (relA and relC respectively) mutants (Fig. 1) . 6) Optimal sporulation, which occurs at some intermediate concentration of the amino acid supplement, results from two opposing effects. The first is that the concentration of the compound suppressing sporulation (GTP or a compound controlled by it) has to decrease enough to retard or prevent growth and to allow initiation of sporulation. The second is that protein synthesis is required for the sporulation process. Therefore, although overly severe amino acid starvation might make possible the initiation of sporulation, it does not permit synthesis of a sufficient quantity of the proteins needed at critical times for the development of sporulation. We found that partial limitation of an amino acid caused a rapid increase in (p)ppGpp, a corresponding decrease in GTP, and extensive sporulation in stringent but not in relaxed strains. 14, 15) However, the relaxed strains sporulated if the concentration of GTP was sufficiently decreased by means other than the stringent response.
The mechanism underlying the initiation of sporulation by ppGpp was identified using a mutant (Myc) resistant to mycophenolic acid, an antibiotic that inhibits GMP synthesis. 16) Since IMP dehydrogenase is the specific target of mycophenolic acid, we reasoned that some mutants resistant to mycophenolic acid might have altered IMP dehydrogenase, in which case they would be less sensitive to inhibition by ppGpp. Using this mutant, we found that sporulation was not induced directly by ppGpp, but was an indirect consequence of the stringent response caused by a decrease in GTP. In addition, using S. griseus, we elucidated the biochemical basis of ppGpp control of IMP dehydrogenase. 13) The intrinsic role of ppGpp in sporulation was further demonstrated using antibiotics. Several antibiotics that bind to ribosomes (e.g., fusidic acid and kasugamycin) inhibit sporulation at concentrations that have little effect on growth, indicating that certain properties of the translation machinery (ribosomes) are specifically needed for sporulation but not for growth. We found that some antibiotics inhibited sporulation by preventing the RelA, stringent factor/ppGpp synthetase I; ppGpp, guanosine 5 0 -diphosphate 3 0 -diphosphate.
decrease in GTP needed to initiate sporulation resulting from the stringent response. 17) We found, however, that decoyinine counteracted the inhibition of sporulation by fusidic acid and kasugamycin, confirming the importance of GTP pool size in the initiation of sporulation.
Obg protein may sense GTP level
It seemed logical that a GTP-binding protein(s) would be involved in sensing a decrease in the GTP pool level that signals differentiation. By monitoring the intracellular GTP pool size in Streptomyces spp., we found that Obg was involved in sensing changes in the nutritional environment, leading ultimately to morphological differentiation. 18, 19) The introduction of multiple copies of obg gene into wild type S. coelicolor suppressed aerial mycelium formation. In addition, propagation in S. coelicolor of certain mutant Obg proteins, generated by site-directed mutagenesis, exerted more accentuated and even opposite effects on the ability to form aerial mycelium, thus providing striking evidence for the significance of Obg during the onset of development in Streptomyces. Under normal conditions, Obg might stimulate the activity of the phosphorelay system, which is believed to be the earliest signal transduction system, leading to activation of transcription factor Spo0A in B. subtilis. [20] [21] [22] In the current model, Obg acts as an intracellular switch to monitor intracellular levels of GTP. In this manner, Obg-GTP promotes growth and inhibits development, whereas decreased GTP levels deactivate Obg. Under starvation conditions during the late growth phase, the intracellular pools of GTP are reduced to less than the threshold level and there is a shift from Obg-GTP to Obg-GDP, triggering the initiation of the developmental program. Hence we hypothesized that the onset of differentiation in streptomycetes is determined by a quantitative balance between Obg and GTP.
II. Initiation of Antibiotic Production
1. relC mutations abolish antibiotic production Members of the genus Streptomyces are of particular interest because they produce a wide variety of industrially and medically important antibiotics. Initiation of antibiotic production, often referred to as ''physiological differentiation,'' usually occurs during the transition between vegetative growth and morphological differentiation of an organism. Identification of the signals that trigger differentiation processes is important in regulating the onset of morphological and physiological differentiation. One potentially significant bacterial regulatory system is the stringent response, which is coupled to amino acid depletion.
To clarify the relationship between ppGpp and antibiotic production, I isolated several relaxed (rel) mutants from Sterptomyces spp. by selecting colonies resistant to thiopeptin, an analog of thiostrepton. [23] [24] [25] All of these Streptomyces rel mutants had alterations in or lacked a ribosomal protein, designated ST-L11, accompanied by a severely reduced ability to produce ppGpp, marking these mutants as relC mutants. 26) One relC mutant of S. griseus was defective in streptomycin production, and all Streptomyces relC mutants have been found to show severely impaired antibiotic production. Since relC mutants accumulated only low levels of ppGpp after nutritional shift-down (about 15% of the wild type) and were deficient in antibiotic production, I hypothesized that ppGpp plays a central role in triggering the onset of antibiotic production. 27) In agreement with this hypothesis, we observed reduced levels of actinomycin biosynthetic enzymes and mRNA in a relC mutant of S. antibioticus. 28) In addition, ppGpp accumulation correlated with transcription of the pathway-specific activator genes for undecylprodigiosin (redD) and actinorhodin (actII-ORF4) synthesis in S. coelicolor, and for bialaphos (brpA) production in S. hygroscopicus. 29, 30) Also, the production of both clavulanic acid and cephamycin C in S. clavuligerus was completely abolished in the relA and relC mutants. 31, 32) The importance of ppGpp in initiating antibiotic production was also demonstrated in B. subtilis. 33) In addition, I found that the morphological differentiation of S. griseus resulted from a decrease in the GTP pool, whereas physiological differentiation resulted from a more direct function of the relA gene product (ppGpp). 27) Since A-factor accumulates in culture media of S. griseus, 34) before a decrease in intracellular GTP content, presumably A-factor and also other autoregulators render the cell sensitive to receive and respond to the specified signal molecules, GTP and ppGpp.
One significant unsolved problem regarding RelC mutations is that all mutants isolated to date grow slowly, suggesting that many observed effects might be indirect, not directly due to the mutation. 35) To resolve this, we isolated a rplK (= relC) mutant, KO-100 of S. coelicolor, from a collection of spontaneous thiostrepton-resistant mutants. KO-100, which possesses a 6-bp deletion within rplK encoding the L11 protein, grew as well as the parent strain did, establishing a correlation between antibiotic production and ppGpp synthesis. 36) Gene disruption experiments have further clarified the role of ppGpp in initiating antibiotic production. 32, [37] [38] [39] [40] For example, a relA null mutant of S. coelicolor strain M600 in which most of the relA coding region had been deleted was unable to produce actinorhodin, accompanied by a failure to accumulate ppGpp. When the relA gene was propagated on a low-copy-number vector, however, actinorhodin production was not only restored but enhanced. These results, from three independent laboratories, supported our hypothesis that ppGpp is a pivotal signal molecule for the onset of antibiotic production.
What is the ppGpp target in antibiotic production?
Our next goal was to clarify the target(s) of ppGpp during the initiation of antibiotic production. In E. coli, ppGpp can affect gene expression by altering the selectivity of RNA polymerase in vivo and in vitro. Many genetic studies of E. coli have suggested that RNA polymerase (RNAP) is the target of ppGpp regulation. [41] [42] [43] The ppGpp-sensitivity domain is close to the rifampicin(Rif)-binding domain of the RNAP -subunit. Its crystal structure showed that Rif-cluster I is involved in the E. coli RNAP active center, 44) indicating that certain mutations in the Rif-binding domain affect the activity of RNAP and might affect the function of the adjacent ppGpp-binding domain. We hypothesized that the impaired ability to produce antibiotic resulting from relA and relC mutations can be circumvented by introducing certain Rif-resistant (rif) mutations into the RNAP -subunit. That is, mutated RNAPs can behave like ''stringent'' RNAP without ppGpp binding. Indeed, we found that certain Rif-resistant isolates from the rel mutants of S. coelicolor and S. lividans regained the ability to produce the antibiotic. 45, 46) Moreover, various point mutations were mapped to Rif-cluster I in the rpoB gene, which encodes the RNAP -subunit. Restoration of actinorhodin production in rel rif double mutant strains was accompanied by increased expression of the pathway-specific regulatory gene actII-ORF4, which is normally decreased in relA and relC mutants. Since ppGpp dependent antibiotic production was bypassed by certain mutations in RNAP, mutant RNAP can function by mimicking the ppGpp-bound form. Indeed, mutant RNAP actually behaved like ''stringent'' RNAP with respect to RNA synthesis. 45) Recent X-ray crystallographic analysis has provided a structural basis for the transcriptional regulation of RNAP activity by ppGpp in Thermus thermophilus. 47) In addition, rRNA promoter activity was found to be controlled directly by GTP pool size, which is modulated by ppGpp via inhibition of IMP dehydrogenase activity. 48) Thus, unlike E. coli, ppGpp cannot inhibit T. thermophilus RNA polymerase activity directly in vivo, similarly to its lack of inhibition of B. subtilis rRNA transcription. 7) In Streptomyces spp., the intracellular ppGpp level has been found to be finely tuned by a novel 52-kDa protein (EshA), which possesses a cyclic AMP-binding domain, indicating that cellular adjustment of the ppGpp level is important to elicit its adaptation ability fully. [49] [50] [51] EshA may provide new insights and opportunities to unravel the molecular signaling events that occur in streptomycetes during the late growth phase.
III. Toward the Establishment of Ribosome Engineering
The dramatic activation of antibiotic production by certain ribosomal mutations (e.g., mutations in the rpsL gene, which encodes ribosomal protein S12) suggested that bacterial gene expression can be altered dramatically by modulating ribosomal proteins or rRNA, which can lead to activation of dormant genes. 52) Hence we sought to construct a system of ribosome engineering as a rational approach to full elicitation of bacterial activity. Below we describe our ribosome engineering and its applicability in outline, focusing especially on the induction of antibiotic overproduction in Streptomyces and Bacillus strains and on the enhancement of tolerance to organic chemicals in Pseudomonas.
One conventional method of modulating ribosomes is to introduce mutations conferring resistance to drugs that attack the ribosome. These drugs include streptomycin, gentamicin, paromomycin, thiostrepton, fusidic acid, kanamycin, chloramphenicol, lincomycin, spectinomycin, and neomycin. Mutants resistant to these drugs frequently possess mutations within a ribosomal component (ribosomal protein, rRNA, or translation factor). One advantage of this method is the ability to select drug-resistant mutants on drug-containing plates, even at frequencies as low as 10 À9 -10 À11 . To obtain a wide variety of mutants, it is necessary to screen them using several concentrations of drugs (e.g., 3-, 30-, and 100-fold of MIC).
Antibiotic overproduction by rpsL (ribosomal protein S12) mutations
Activation of actinorhodin production. A strain of S. lividans, TK24, has been found to produce large amounts of actinorhodin (Act) under normal culture conditions ( Fig. 2A) . Genetic analyses revealed that a streptomycin-resistant mutation str-6 in TK24 is responsible for activation of Act synthesis, and that str-6 is a point mutation in the rpsL gene, which encodes the ribosomal protein S12, changing Lys-88 to Glu (K88E mutation). 52) In addition, streptomycin-resistant mutations improved Act production in wild-type S. coelicolor ( Fig. 2A) , 53) and circumvented the detrimental effects on Act production in certain developmental mutants (relA, relC, and brgA). 52) These mutations result in the alteration of Lys-88 to Glu (K88E), or of Arg (K88R), or of Arg-86 to His (R86H) in the S12 protein.
In addition, a paromomycin-resistant rpsL mutation (P91S) was also found to activate Act production. 54) These findings indicate that antibiotic production in streptomycetes is significantly controlled by the translational machinery in the ribosome.
In the Act biosynthetic gene cluster, actII-ORF4 is pathway-specific, and its level of expression directly regulates Act production. 55) Expression of the ActII-ORF4 protein was strongly enhanced in rpsL mutants producing high levels of Act, and increases in this regulatory protein were attributed to enhanced expression of actII-ORF4 mRNA. 56) In addition to rpsL mutations associated with high levels of resistance to streptomycin, another type of mutation (the ND mutation), conferring low-level resistance to streptomycin, also gave rise to similar increases in Act production. 52, 53) These mutants appear relatively frequently (10 À5 to 10 À7 ) and possess a high level of activity of S-adenosylmethionine (SAM) synthetase, a product of the metK gene. 57) The introduction of a high-copy-number plasmid containing the metK gene into the wild-type strain resulted in hyperproduction of Act. Furthermore, the addition of SAM to the culture medium of wild-type cells activated Act production, indicating that enhanced Act production in ND mutants was due at least in part to overexpression of SAM synthetase, which leads to elevated levels of intracellular SAM. In addition, the introduction of a multicopy plasmid containing the S. spectabilis metK gene into S. lividans induced Act production. 58) SAM donates methyl groups during the methylation of various biological substances (DNA, RNA, proteins, and other small molecules). Of interest was the fact that overexpression of the metK gene stimulated the expression of the pathway-specific regulatory gene actII-ORF4. Furthermore, the addition of SAM caused overproduction of streptomycin (by S. griseus) and bicozamycin (by S. griseoflavus), 59) indicating that SAM is a common intracellular signal molecule for the onset of secondary metabolism in Streptomyces and Bacillus.
60-62)
Mechanism of activation. Ribosomal protein S12, a component of the 30S subunit in bacteria, is best characterized as having a role in the selection efficiency of cognate tRNAs by enhancing accuracy. Most mutations in S12 associated with streptomycin resistance lead to an error-restrictive phenotype. 63, 64) We found that the K88E rpsL mutant of S. coelicolor (corresponding to position 87 in E. coli S12), which shows enhanced Act production, exhibits aberrant protein synthesis activity. 65, 66) That is, the K88E mutation, like the classic E. coli S12 mutations K42N and K42T, confers a restrictive phenotype in addition to streptomycin resistance and exhibits a high level of protein synthesis activity in vivo during the late growth phases. In addition, K88E mutant ribosomes are structurally more stable under stress conditions, such as amino acid starvation and low magnesium concentrations, suggesting that the increased stability of the 70S complex in S. coelicolor K88E is responsible for the aberrant activation of protein synthesis. This observation is supported by our recent finding that the E. coli K87E mutant also shows aberrant protein synthesis activity during the late growth phase. 67) Thus a change from Lys to Glu at position 88 in S12 protein enhances protein synthesis under starvation conditions. This characteristic must be highly advantageous for protein production from newly transcribed genes, such as those involved in antibiotic production, during the late growth phase. More recently, we found that increased expression of translation factor RRF (ribosome recycling factor) also contributes to enhancement of protein synthesis during the late growth phase of the K88E rpsL mutant. 67) This finding suggests that enhanced protein synthesis was due to both the greater stability of the 70S ribosome and the elevated levels of RRF caused by the K88E rpsL mutation, resulting in overproduction of the antibiotic (Fig. 3) .
Unlike rpsL mutations, str mutations, which confer low-level resistance to streptomycin, remained unknown for 60 years. Using comparative genome sequencing, we found recently that low-level resistance was caused by mutations in rsmG, which encodes a 16S rRNA methyltransferase containing a SAM binding motif A, Activation of antibiotic production by rpsL (encoding ribosomal protein S12) mutations in S. lividans 66 and S. coelicolor A3(2). K88E indicates a lysine-to-glutamate mutation at amino acid 88. B, Activation of antibiotic production by gentamicin-resistance (gen), fusidic acidresistance ( fus), or thiostrepton-resistance (tsp) mutation. Strains were incubated for 5 d on GYM agar medium. Blue color represents the antibiotic actinorhodin. (Fig. 4A) . 68) HPLC analysis showed that the ÁrsmG mutant failed to methylate 16S rRNA, possibly at position G518, which corresponds to position G527 of E. coli (Fig. 4B) . Like certain rpsL mutants, the ÁrsmG mutant exhibited enhanced protein synthesis activity during the late growth phase. Consistently with earlier work using a ND mutant, 57) the ÁrsmG mutant exhibited increased SAM synthetase activity, which mediated overproduction of the antibiotic. Spontaneous rsmG mutations arose at a 1,000-fold higher frequency than rpsL mutations. These findings provide new insight into the role played by rRNA modification in the activation of secondary metabolism in Streptomyces.
68)
The K88E mutation in S12 results in preferential transcription of specific genes, such as actII-ORF4 and redD, during the late growth phase. Likewise, the ÁrsmG mutant displayed enhanced expression of actII-ORF4. 68) Although it is not yet clear how the K88E rpsL and ÁrsmG mutations mediate such preferential gene transcription, higher-order regulatory proteins might govern the expression of these pathway-specific regulatory genes, and expression of these presumptive regulatory proteins might be significantly affected under conditions associated with enhanced protein synthesis during the stationary phase. Although it is not yet known how rsmG mutations upregulate metK transcription, our finding that the combination of rsmG and rpsL mutations exerts a synergistic effect on antibiotic production is intriguing in considering strategies for strain improvement. 68) rpsL mutations by site-directed mutagenesis. Of the rpsL mutations identified to date in S. coelicolor and S. lividans, K43N, K43R, K43T, K88E, K88R, and P91S, only two, K88E and P91S, effectively activated antibiotic production in wild-type cells. This finding suggests that certain mutations around the Lys-88 region have a distinct effect on antibiotic production, and that isolation of such mutants can lead to the development of antibiotic-overproducing strains. However, since most of those mutations are not likely to confer resistance to streptomycin, it is impossible to identify such mutations by their resistance to this drug. Using site-directed mutagenesis, we generated seven novel rpsL mutations, R86L, V87K, K88G, D89R, L90K, G92D, and R94G, and introduced these mutant genes into wild type S. lividans using a low-copy-number plasmid. 69) Of these seven mutations, two, L90K and R94G, activated the production of a red-pigmented antibiotic, undecylprodigiosin, by S. lividans, to a greater degree than that shown by the streptomycin-resistant K88E mutation. Neither the L90K nor the R94G mutation conferred increased resistance to streptomycin and paromomycin, indicating the non-availability of these mutant alleles among the resistant isolates. These results demonstrate the efficacy of gene engineering techniques in ribosome engineering.
Effect of str and rpoB mutations in various bacteria
Antibiotic overproduction by str mutations. The impairment in antibiotic production resulting from a relA or relC mutation was completely restored by introducing mutations conferring resistance to streptomycin (str), suggesting that certain str mutations allow initiation of antibiotic production without the requirement for ppGpp. This finding offers a possible strategy for improving antibiotic productivity. Indeed, in addition to actinorhodin production by S. coelicolor and S. lividans, introduction of the str mutation was effective in enhancing antibiotic production by other bacteria.
(i) Effect of str mutation on Streptomyces spp. In S. chattanoogensis, nearly half of the str mutants exhibited a significantly increased ability (greater than 5-fold) to produce fredericamycin, with one strain showing a 26-fold higher antibiotic production than the wild-type strain. 70) Similarly, str mutants of S. antibioticus and S. lavendulae producing high levels of actinomycin and formycin respectively, were detected at a relatively high frequency (3 to 4%). 70) Thus, like actinorhodin production by S. coelicolor, the introduction of mutations conferring resistance to streptomycin enhanced antibiotic production by other Streptomyces spp.
(ii) Effect of str mutations on Bacillus and Pseudomonas. Introduction of the str mutation also improved antibiotic productivity by Bacillus spp. and Pseudomonas spp. 70) For example, in B. cereus and P. pyrrocinia, the frequency of antibiotic overproducing strains among str mutants ranged from 7 to 30%. Unlike S. coelicolor, the str mutation in B. subtilis was at amino acid position K56, corresponding to K42 in E. coli, of ribosomal protein S12. Mutations K56R, K56T, and K56Q effectively increased antibiotic production, whereas mutations K56I and K56N were ineffective.
Antibiotic overproduction by rpoB (RNA polymerase) mutations. To test the feasibility of rif mutation in the production of antibiotic producing strains, we attempted to activate the antibiotic biosynthetic gene cluster in S. lividans. We found that biosynthesis of actinorhodin, undecylprodigiosin, and calcium-dependent antibiotics was markedly activated by introducing specific types of rif mutations into the rpoB gene. 56, 71) Moreover, although B. subtilis normally does not produce a detectable amount of aminosugar antibiotic neotrehalosadiamine (NTD), the introduction of a certain rifampicin-resistant rpoB mutation activated dormant ability to produce NTD. 72 ) Surprisingly, NTD acted as an autoinducer of its own biosynthesis operon by interacting directly with the NtdR protein. In our model, the NtdR protein dramatically stimulates ntdABC transcription by binding to its promoter region.
Enzyme overproduction. The introduction of drugresistant mutations has also been found to be effective in improving enzyme productivity. Several str mutants of B. subtilis have been found to produce increased amounts (20-30%) of -amylase and protease. 73) In addition, rpoB mutations were effective for the overproduction (1.5-to 2-fold) of extracellular enzymes such as amylase and protease (Jorgensen et al., personal communication). Hence these methods might be applicable in the overproduction of other enzymes produced by various microorganisms, especially during the late growth phase.
Increase in chemical tolerance in Pseudomonas. The use of microorganisms for bioremediation has increased recently.
74) The ribosome engineering approach has been effective not only in the overproduction of useful metabolites but also in improving tolerance to aromatic compounds of bacteria applicable in bioremediation.
Certain str, gen, and rif mutants of Pseudomonas putida, resistant to streptomycin, gentamicin, and rifampicin respectively, have been found to tolerate an aromatic compound 4-hydroxybenzoate (4HBA), as well as a variety of organic chemicals, such as 3-hydroxybenzoate, aliphatic and heterocyclic compounds, chlorobenzoates, and the organic solvents toluene and mxylene. 75 ) str, gen, and rif-phenotypes occurred in spontaneous 4HBA-tolerant mutants, that had been selected by successively increasing 4HBA concentrations, from 0.8 to 5%, suggesting that breeding approaches by traditional mutagenesis often involve mutations in a ribosomal component or RNAP. The ability of [
14 C]-4HBA to be taken up by the membrane transport system was reduced in the mutants, accounting at least partly for their enhanced tolerance to 4HBA. 75) 3. Combined drug-resistance mutations Model experiment. Improvement of the productivity of commercially viable microbiotic strains is an important area of microbiology, especially since wild-type strains isolated from nature usually produce only low levels (1-30 mg/ml) of antibiotics. Current methods of improving the productivity of industrial microorganisms range from the classical random approach to using highly rational methods, e.g., metabolic engineering. 76, 77) Although classical methods are still effective, even without using genomic information or genetic tools to generate highly productive strains, these methods are time-and resource-intensive.
Introduction of combined drug-resistance mutations was found to be quite effective in increasing antibiotic production in a hierarchical order. 56) Construction of double mutants (e.g., str gen and str rif) by introducing gentamicin or rifampicin resistance into an str mutant of S. coelicolor resulted in further increased (1.7 to 2.5-fold higher) actinorhodin production. Likewise, triple mutants (str gen rif) produced even more antibiotic, eventually resulting in a mutant that produced 48 times more actinorhodin than the wild-type strain. These single, double, and triple mutants displayed in hierarchical order a remarkable increase in production of the pathway-specific regulatory protein ActII-ORF4.
Applicability to industrial strains. Unlike wild-type strains, improvement of industrial strains is much more difficult in general, as antibiotic production has already been raised by various genetic and physiological approaches. Using a S. albus strain engineered to produce industrial amounts (10 mg/ml) of salinomycin, we showed that the introduction of drug-resistance mutations can result in even further strain improvement. 78) Mutants with enhanced salinomycin production were detected at a high incidence (7 to 12%) in isolates spontaneously resistant to streptomycin, gentamicin, or rifampicin. In addition, by introducing a triple mutation, we increased salinomycin production by an industrial strain 2.3-fold.
Applicability of ribosome engineering to cell-free translation systems
Cell-free translation systems have been used in the high-throughput production of many proteins of foreign origin, but no studies have focused on high-throughput production relative to the ribosome. An E. coli str mutant, in which Lys-42 was replaced with Thr (K42T) in the S12 protein, showed 1.3-fold higher protein production than the wild type. 79) Therefore, ribosome engineering may be an effective strategy to enhance protein production in E. coli-based cell-free translation systems.
The presence of ppGpp in plants
Plants have a complex signal transduction network activated in response to stressful conditions, including pathogenic infection, wounding, heat shock, drought, and high salinity. Despite the apparent significance of ppGpp in bacterial gene expression, the importance of ppGpp in plant biology has been largely overlooked. Recently, we demonstrated unambiguously that ppGpp is produced in the chloroplasts of plant cells in response to stressful conditions. 80) Levels of ppGpp increased markedly when the plants were subjected to such biotic and abiotic stresses as wounding, heat-shock, high salinity, acidity, heavy metal exposure, drought, and ultraviolet irradiation. Abrupt changes from light to dark, as well as treatment with the plant hormones jasmonic acid, abscisic acid, and ethylene, resulted in elevations in ppGpp levels. In vitro, chloroplast RNAP activity was inhibited in the presence of ppGpp, demonstrating the existence of a bacteria-type stringent response in plants. Given the significance of ppGpp in bacterial physiology, it is likely that ppGpp plays a critical role in adjusting plant physiology. Our findings are also consistent with recent reports demonstrating the existence of RelA homologs in Arabidopsis and Chlamydomonas. [81] [82] [83] A detailed understanding of ppGpp functions and its activation of signaling cascades should provide insight into plant evolution and adaptation to environmental changes, as well as making contributions to plant breeding.
IV. Conclusion and Future Prospects
We have found that cellular function can be altered dramatically by modulating the ribosome with the aid of drug-resistance mutation techniques.
84) The outline of this concept, named ribosome engineering, is depicted in Fig. 5 . Our approach is characterized by a focus on ribosomal function during the late growth (stationary) phase, the importance of which has been largely overlooked in the study of ribosomes. In summary, our novel breeding approach is based on two different aspects, modulation of the translational apparatus by induction of str and gen mutations and modulation of the transcriptional apparatus by induction of a rif mutation. Modulation of these two mechanisms can function cooperatively to increase antibiotic production. Similarly to the str mutation, the introduction of mutations conferring resistance to fusidic acid ( fus) or thiostrepton (tsp) enhances antibiotic production (Fig. 2B) . Moreover, these fus and tsp mutations encode aberrant protein synthesis activity (unpublished data). Ribosome engineering should be useful not only for strain improvement but also in searching for novel compounds, since this technique activates the dormant genes in bacteria. In fact, we have found new antibiotics from B. subtilis 72, 85) and Streptomyces spp. (unpublished data). Pursuit of these subjects in relation to ribosomal function might be useful in developing the study of bacterial ribosomes, eventually leading to practical applications of basic study in applied microbiology.
ppGpp-GTP dual control in B. subtilis
Bacilysin is a simple peptide antibiotic produced by B. subtilis. CodY protein regulates the expression of various stationary-phase genes by sensing the intracellular GTP level. 86) In fact, sporulation and genetic competence can be initiated by the addition of decoyinine (a GMP synthetase inhibitor) or by inactivation of CodY. 87) Since codY disruption increased the transcription of the bacilysin biosynthesis cluster, it is likely that the CodY protein controls bacilysin production. However, the codY relA double mutant does not produce bacilysin, indicating that ppGpp is a positive regulator, even in B. subtilis, and that GTP functions as a negative regulator, producing a synergistic effect on antibiotic production. Thus, unlike antibiotic production in Streptomyces spp., bacilysin production in B. subtilis is controlled by a dual regulation system composed of the guanine nucleotides ppGpp and GTP.
88) The codY gene is a feasible target for activation of secondary metabolism, since many low G þ C Gram-positive bacteria contain a CodY homolog.
ADP-Ribosylation and differentiation
ADP-ribosylation is a two-step enzymic reaction, in which NAD is hydrolyzed by NAD-glycohydrolase to nicotinamide and adenosinediphosphoribose (ADPR) and ADPR is bound to specific acceptor proteins by ADP-ribosyltransferase. 89 ) ADP-ribosylation can be considered a type of metabolic regulation, along with phosphorylation, adenylylation, uridylation, and methylation; that is, the ADP-ribosylated protein can lose its activity but later be reactivated by enzymic de-ADPribosylation. These processes play a significant role in various biologically important events, such as DNA repair, modification of RNA polymerase, inhibition of protein synthesis, regulation of cell proliferation, and differentiation. Working with S. coelicolor and B. subtilis, we demonstrated the possible significance of this rather novel modification system in microbial differentiation, [90] [91] [92] [93] suggesting that further study of ADPribosylation might provide new insight into the mechanisms of initiation of differentiation and secondary metabolism.
Applicability of ribosomal protein L30 in taxonomy
Since in the course of studying the ribosomal function I became aware of the heterogeneity of ribosomal proteins among Streptomyces spp., 94) I developed a method of identifying and classifying actinomycetes based on analysis of ribosomal L30 proteins (a component of the 50S subunit), i.e., the electorphoretic mobilities and N-terminal amino acid sequences of the L30 proteins were determined. [95] [96] [97] [98] [99] [100] [101] This approach has also proven to be effective in studying the phylogeny of bacteria other than actinomycetes, not only at the generic level but also at the species level. [102] [103] [104] Thus this new approach can be utilized in the taxonomy of bacteria, in addition to traditional ribosomal 16S rRNA sequence analysis.
Significance of low-level streptomycin resistance mutation (rsmG) in tuberculosis
Streptomycin was first shown to have potent activity against Mycobacterium tuberculosis in 1944; 105) two years later, the first mutants resistant to streptomycin were reported, and many strains of M. tuberculosis are streptomycin resistant. 106) Streptomycin mutants can be classified into two distinct types, depending on whether they exhibit high-or low-level streptomycin resistance. Resistance to streptomycin is often mediated by mutations within rrs, a 16S rRNA gene, or rpsL, which encodes the ribosomal protein S12, but these mutations are found in only a limited proportion of clinically isolated streptomycin-resistant M. tuberculosis strains. 107) Recently, we found that mutations within the rsmG gene, which encodes a 16S rRNA methylase, confers low-level streptomycin resistance, and that they are found in 33% of resistant M. tuberculosis isolates. 108) These mutations are clinically significant, since they emerge spontaneously at a high frequency (10 À6 ) and lead to the emergence of high-level streptomycinresistant mutants at a frequency more than 2,000 times greater than that seen in wild-type strains. 108) Further studies of the precise function of RsmG may provide a basis for developing strategies to suppress pathogenic bacteria, including M. tuberculosis.
Why antibiotics?
While antibiotics are superior in the treatment of infectious diseases, they have been thought to have no intrinsic biological roles in the producing organisms. NTD (neotrehalosadiamine), an amino-sugar antibiotic produced by several Bacillus species, has been shown to function as an autoinducer, activating its own biosynthetic operon, ntdABC. 72) Although the B. subtilis wild type strain produces less-than-detectable amounts of NTD, we found recently that a trace amount (0.5-3 mg/ ml) of NTD is sufficient to induce expression of glcP, a gene that controls glucose uptake. 109) Thus, by stimulating the transcription of the ntdABC-glcP operon, NTD functions as a glucose uptake modulator in B. subtilis, demonstrating the ''physiological role'' of an antibiotic in the producing organism. This is especially important due to the central role of glucose metabolism in many metabolic systems. Although it is not clear whether NTD can be considered a typical antibiotic, it may offer a feasible system for the study of the physiological roles of antibiotics in the producing bacteria.
